Shareholder information

Upcoming events

H1 2020 results

H1 2020 results virtual roadshow, management

This data might not be the latest available

Annual General Meeting

AstraZeneca’s 2020 Annual General Meeting (AGM) took place on 29 April 2020. To help ensure the safety and security of our workforce and shareholders during the COVID-19 pandemic, the AGM took place behind closed doors in compliance with the ‘Stay at Home Measures’ passed into law in England and Wales on 26 March 2020. Shareholders were encouraged to vote on the AGM resolutions by appointing the Chairman of the AGM as their proxy.

Shareholder forms

365备用网址APPYou can download a selection of our registrar instruction forms here. If you can't find the form you require please go to the


Completed forms should be returned to:

Equiniti Limited
Aspect House
Spencer Road
West Sussex
BN99 6DA

365备用网址APPFor more information, shareholder services and changes to personal details, visit the Equiniti website.

Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Henry Wheeler


Josie Afolabi

BioPharmaceuticals (Respiratory & Immunology)

Craig Marks

365备用网址APPFinance, fixed income

Christer Gruvris

365备用网址APPBioPharmaceuticals (CV, Metabolism)

365备用网址APPTom Waldron

Other medicines

Jennifer Kretzmann

365备用网址APPCorporate access, retail investors

Nick Stone

365备用网址APPBioPharmaceuticals (Renal), ESG

365备用网址APPUS general enquiries